Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery - Concepedia

Concepedia

Publication | Open Access

Increased Incidence of Gestational Diabetes in Women Receiving Prophylactic 17α-Hydroxyprogesterone Caproate for Prevention of Recurrent Preterm Delivery

DOI Full Paper Access

93

Citations

12

References

2007

Year

Andrei Rebarber, Niki Istwan, Karen Russo-Stieglitz, Jane Cleary‐Goldman, Debbie Rhea, Gary Stanziano, Daniel H. Saltzman

Abstract

The use of 17P for the prevention of recurrent preterm delivery is associated with an increased risk of developing GDM. Early GDM screening is appropriate for women receiving 17P prophylaxis.

References

	Year	Citations

Page 1